Antidiabetic Medications and Bladder Cancer Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Saved in:
Bibliographic Details
Title: Antidiabetic Medications and Bladder Cancer Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Authors: Rao Y; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands; Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands., Meng S; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., Yu EY; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands; Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Epidemiology & Biostatistics, School of Public Health, Southeast University, Nanjing, China., Chen Y; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands; Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands., van Alebeek R; Maastricht University Library, Maastricht University, Maastricht, the Netherlands., Al-Zalabani AH; Department of Family and Community Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia., Zeegers MP; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands; Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands., Wesselius A; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands; Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands. Electronic address: anke.wesselius@maastrichtuniversity.nl.
Source: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2026 Mar; Vol. 32 (3), pp. 442-454. Date of Electronic Publication: 2025 Dec 17.
Publication Type: Journal Article; Systematic Review; Meta-Analysis; Review
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9607439 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1530-891X (Print) Linking ISSN: 1530891X NLM ISO Abbreviation: Endocr Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-891X
DOI:10.1016/j.eprac.2025.11.017